Palvella Therapeutics, Inc. (PVLA): Revenue
Older than the company's other figures. The latest Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$42.81M
Year ended 2023-12-31
+13.4%
3-year compound annual growth
+8.0%
5-year compound annual growth
+13.2%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $42.81M | +65.3% | 2024-03-29, From 2023-01-01 |
| 2022-12-31 | $25.90M | -17.6% | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | $31.42M | +7.1% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $29.32M | -36.6% | 2022-03-02, From 2020-01-01 |
| 2019-12-31 | $46.28M | +59.0% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $29.10M | +15.1% | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | $25.27M | +333.5% | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | $5.83M | +98.9% | 2018-03-15, From 2016-01-01 |
| 2015-12-31 | $2.93M | -45.4% | 2017-03-30, From 2015-01-01 |
| 2014-12-31 | $5.37M | -56.8% | 2016-03-23, From 2014-01-01 |
| 2013-12-31 | $12.43M | n/a | 2015-03-30, From 2013-01-01 |